Volume Alert - SAN 8.47 Banco Santander $SAN Hit a high

New Post Public Reply Private Reply Replies (0) Message Board
leahanne
Volume Alert - SAN 8.47 Banco Santander $SAN Hit a high today of 8.53 Closing the day 10:30 at 8.47 +0.01 +0.12% With a day low of 8.46 and a total volume of 1,710,867.

SAN Recent Posts: http://investorshangout.com/Banco-Santander-S...SAN-52719/

SAN Banco Santander Recent Headline News

Sanofi and Regeneron Announce New Results from Six Phase 3 Trials Showing that Alirocumab Significantly Reduced LDL Cholesterol
PR Newswire - Wed Nov 19, 7:15AM CST
Sanofi and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced new detailed positive results from six Phase 3 ODYSSEY trials that showed alirocumab significantly reduced low-density lipoprotein cholesterol (LDL-C, or "bad" cholesterol). Alirocumab is an investigational fully human monoclonal antibody targeting the protein PCSK9 (proprotein convertase subtilisin/kexin type 9) that is being evaluated for its ability to lower LDL-C.
SAN: 8.46 (unch), SNY: 48.26 (-0.10), REGN: 417.66 (+4.44)

Regeneron and Sanofi Announce New Results from Six Phase 3 Trials Showing that Alirocumab Significantly Reduced LDL Cholesterol
PR Newswire - Wed Nov 19, 7:15AM CST
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced new detailed positive results from six Phase 3 ODYSSEY trials that showed alirocumab significantly reduced low-density lipoprotein cholesterol (LDL-C, or "bad" cholesterol). Alirocumab is an investigational fully human monoclonal antibody targeting the protein PCSK9 (proprotein convertase subtilisin/kexin type 9) that is being evaluated for its ability to lower LDL-C.
SAN: 8.46 (unch), SNY: 48.26 (-0.10), REGN: 417.66 (+4.44)

SmarTrend Watching for Potential Pullback in Shares of Banco Santander After 1.20% Gain
Comtex SmarTrend(R) - Tue Nov 18, 4:44PM CST
Banco Santander (NYSE:SAN) traded in a range yesterday that spanned from a low of $8.45 to a high of $8.53. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $8.42 on volume of 18.9 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
SAN: 8.46 (unch)

Sanofi Names Chief Scientific Officer Gary Nabel as Sanofi Ebola Response Coordinator
PR Newswire - Tue Nov 18, 10:22AM CST
As part of its contribution to the global response to the Ebola epidemic, Sanofi announced today that it has appointed Chief Scientific Officer Dr. Gary J. Nabel, M.D., Ph.D., as its Ebola response coordinator.
SAN: 8.46 (unch), SNY: 48.26 (-0.10)

Banco Santander Down 12.1% Since SmarTrend Downtrend Call (SAN)
Comtex SmarTrend(R) - Mon Nov 17, 10:54AM CST
SmarTrend identified a Downtrend for Banco Santander (NYSE:SAN) on September 29th, 2014 at $9.47. In approximately 2 months, Banco Santander has returned 12.14% as of today's recent price of $8.32.
SAN: 8.46 (unch)

Undervalued Global Banking Groups Too Cheap To Ignore
Sebastien Couvidat - at Seeking Alpha - Sun Nov 16, 11:33PM CST

BCS: 14.83 (-0.05), SAN: 8.46 (unch), C: 53.55 (-0.26), BAC: 17.01 (-0.13)

Genzyme's Lemtrada Approved by the FDA
Business Wire - Fri Nov 14, 8:00PM CST
Genzyme, a Sanofi company, announced today that the U.S. Food and Drug Administration (FDA) has approved Lemtrada(TM) (alemtuzumab) for the treatment of patients with relapsing forms of multiple sclerosis (MS). Because of its safety profile, the use of Lemtrada should generally be reserved for patients who have had an inadequate response to two or more drugs indicated for the treatment of MS.
SAN: 8.46 (unch), SNY: 48.26 (-0.10)

Market Maker Surveillance Report. GILD, QCOM, SAN, MNKD, HST, BABA, Bullishly Biased Price Friction For Monday, November 10th 2014
M2 - Tue Nov 11, 2:31AM CST
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Monday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Monday there were 4913 companies with "abnormal" market making, 2783 companies with positive Friction Factors and 2128 companies with negative Friction Factors. Here is a list of the top companies with Abnormal Price Friction (bullish bias) in their stock prices. This means that there was more selling than buying in the stocks and their stock prices rose. GILEAD SCIENCES, INC. (NASDAQ:GILD), Qualcomm Inc (NASDAQ:QCOM), Banco Santander SA (NYSE:SAN), Mannkind Corp (NASDAQ:MNKD), Host Hotels and Resorts Inc (NYSE:HST), (NYSE:BABA). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .
SAN: 8.46 (unch), HST: 22.45 (-0.31), GILD: 102.04 (-1.67), QCOM: 70.85 (-1.16), MNKD: 6.58 (-0.02), BABA: 109.99 (-0.82)

Regeneron and Sanofi Announce Positive Results from Phase 2b Study of Dupilumab in Patients with Moderate-to-Severe Asthma
PR Newswire - Tue Nov 11, 12:00AM CST
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi (EURONEXT: SAN and NYSE: SNY) today announced positive results from the interim analysis of a dose-ranging Phase 2b study of dupilumab in adult patients with uncontrolled moderate-to-severe asthma. Dupilumab is an investigational therapy blocking IL-4 and IL-13, two cytokines required for the Th2 immune response.
SAN: 8.46 (unch), SNY: 48.26 (-0.10), REGN: 417.66 (+4.44)

Shares of SAN Down 12.4% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Mon Nov 10, 9:52AM CST
SmarTrend identified a Downtrend for Banco Santander (NYSE:SAN) on September 29th, 2014 at $9.47. In approximately 1 month, Banco Santander has returned 12.45% as of today's recent price of $8.29.
SAN: 8.46 (unch)

Promises, Promises; Markets Move on Draghi: Best of Kass
at The Street - Sun Nov 09, 4:05PM CST
In highlights from his trading diary of the past week, Doug Kass says the European Central Bank is jolting the markets and Monitise is looking more shaky.
KO: 44.00 (+0.47), SAN: 8.46 (unch), DVN: 64.82 (+0.33), XLP: 48.40 (+0.14), V: 249.32 (-0.41), SPY: 204.94 (-0.61), IBM: 161.29 (-0.60), FB: 73.92 (-0.42), XOM: 95.18 (+0.31), PG: 88.45 (+0.50), TWTR: 39.79 (-0.82), CVX: 116.05 (+0.58)

Providence drops suit vs. Santander over lending
By JENNIFER McDERMOTT - AP - Fri Nov 07, 12:42PM CST
PROVIDENCE, R.I. (AP) — Santander Bank has agreed to give $1.3 million in grants to support low- and moderate-income neighborhoods in Providence to resolve a lawsuit filed by the city.
SAN: 8.46 (unch), SANW: 3.47 (-0.13)

GE Capital closes sale of GE Money Bank
Seeking Alpha - at Seeking Alpha - Thu Nov 06, 8:13AM CST

SAN: 8.46 (unch), GE: 26.84 (-0.17)

Update: Banco Santander Earnings
The Investment Doctor - at Seeking Alpha - Wed Nov 05, 9:45AM CST

SAN: 8.46 (unch)

Genzyme Announces Enrollment of First Patient in Phase II Vatelizumab Trial in Relapsing Remitting Multiple Sclerosis
Business Wire - Tue Nov 04, 5:00AM CST
Genzyme, a Sanofi company, announced today enrollment of the first patient in a multicenter Phase II clinical trial to evaluate Genzyme's investigational infusion therapy vatelizumab in patients with relapsing remitting multiple sclerosis (RRMS). The trial, called EMPIRE, is designed to assess the efficacy of vatelizumab vs. placebo in RRMS patients. The safety, tolerability and pharmacokinetics of vatelizumab will also be assessed.
SAN: 8.46 (unch), SNY: 48.26 (-0.10)

Santander Brasil slides continues as Banco Santander boosts stake
Seeking Alpha - at Seeking Alpha - Mon Nov 03, 10:34AM CST

SAN: 8.46 (unch), BSBR: 5.58 (+0.07)

Banco Santander Brasil (BSBR) Stock Continues to Sink After Share Buyout
at The Street - Mon Nov 03, 10:03AM CST
Banco Santander Brasil (BSBR) stock continues to tumble after its parent company raised its stake in the Brazilian unit to 88.3% last Friday.
SAN: 8.46 (unch), BSBR: 5.58 (+0.07)

Sanofi Pasteur Announces FDA Approval of Updated Prescribing Information for Fluzone® High-Dose Vaccine for Adults 65 and Older
PR Newswire - Mon Nov 03, 7:30AM CST
Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental biologics license application (sBLA) for Fluzone® High-Dose (Influenza Vaccine) to include efficacy data in the Prescribing Information. These data demonstrate that Fluzone High-Dose vaccine provided improved protection against influenza ("the flu" compared to standard-dose Fluzone vaccine (trivalent intramuscular formulation) in adults 65 years of age and older.
SAN: 8.46 (unch), SNY: 48.26 (-0.10)

Conference Participation, Dividend, Upcoming Annual Meeting, Training Program, and Promotional Event - Research Reports on Santander Brasil, Goldman Sachs, Visa, Banco Santander and American Express
PR Newswire - Thu Oct 30, 7:30AM CDT
Today, Analysts Review released its research reports regarding Banco Santander Brasil SA (NYSE: BSBR), The Goldman Sachs Group Inc. (NYSE: GS), Visa Inc. (NYSE: V), Banco Santander, S.A. (NYSE: SAN) and American Express Company (NYSE: AXP). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7556-100free.
SAN: 8.46 (unch), V: 249.32 (-0.41), GS: 189.68 (+0.04), AXP: 90.38 (-0.20), BSBR: 5.58 (+0.07)

Sanofi: Sanofi Delivers Business EPS Growth of 10.3% at CER
PR Newswire - Tue Oct 28, 7:34AM CDT
Sanofi (NYSE: SNY; EURONEXT: SAN)
SAN: 8.46 (unch), SNY: 48.26 (-0.10)

Banco Santander S.A. (SAN) Stock Research Links

SAN Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

ZAKSIMLAB Tests Kombucha and Salmon Snack Pairing in Cafes

Updated Category News Views 48

A fish-based chip beside a fizzy tea mix is an odd little commercial wager, and that is exactly why ZAKSIMLAB's latest move deserves a look. The Seoul food brand launched Salmon Crunch Protein Chips in September, then put the snack next to its powdered kombucha at the 2026 Cafe & Bakery Fair Season 2. This is not a grand earnings story; no sales, pricing, store-count, or...

Continue Reading
Vusion Lands a 2,000-Store dm EdgeSense Rollout in Germany

Updated Category News Views 135

A drugstore shelf rarely gets anyone's pulse racing, but 2,000 of them wired into a live digital system is a serious retail deployment. Vusion has expanded its partnership with dm-drogerie markt to roll out its newest EdgeSense platform across about 2,000 German stores over the next three years. This is not a glossy one-store pilot with a ribbon-cutting and a few tablets...

Continue Reading
Chaos Zero Nightmare's Award Is a Useful Signal for Games

Updated Category News Views 189

A story award can be easy to sneer at until a live-service game earns one across three markets. Smilegate's Chaos Zero Nightmare, a dark fantasy roguelike RPG developed by Super Creative, was named Best Story in Google Play's Best of 2026 awards for Taiwan, Hong Kong and Macau. That is not a sales figure, not a profit disclosure, and certainly not proof that a hit has...

Continue Reading
Scalefusion’s Platinum Win Sharpens Its Brand Story

Updated Category News Views 14

A Film Is Not a Balance Sheet A slick brand film cannot patch a leaky product, but it can make a complicated platform easier to remember. That is the sensible takeaway from Scalefusion’s Platinum Level win at the 2026 MarCom Awards for “One Platform. One Agent. We are Scalefusion.” The recognition is for creative execution, not commercial performance, and anybody...

Continue Reading
AMPERA Joins Berto to Power Future Energy Innovations

Updated Category News Views 172

The Power Play You Didn't See Coming AMPERA and Berto just made a move that could stir up some serious waves in the energy sector. They've inked a business combination deal set to push advanced energy technology to the forefront. With AMPERA's valuation clocking in at roughly $900 million, this partnership aims to bring cutting-edge power solutions from concept to market....

Continue Reading
My Home Delivery's Bold Move in Big & Bulky Sector

Updated Category News Views 194

Redefining Big & Bulky Deliveries with AI Let me tell you, the logistics world isn't for the timid, and My Home Delivery (MHD) is swinging for the fences with their latest tech platform. These folks are rolling out an AI-driven system that promises to turn the bulky goods market on its head. Imagine moving your brand new fridge or that king-size bed across town without...

Continue Reading
Mike Blyth’s Hall of Fame Honors a Builder’s Legacy

Updated Category News Views 147

Recognition earned in the hangar, not a boardroom Aircraft design has a ruthless way of exposing empty talk, which is why Mike Blyth’s November 11 induction into the EAA Homebuilders Hall of Fame carries real weight. The Experimental Aircraft Association’s honor, presented in the Eagle Hangar at the EAA Aviation Museum in Oshkosh, Wisconsin, recognizes a career built...

Continue Reading
ISDN Holdings: Leading APAC Automation with Innovation

Updated Category News Views 81

Pioneering Automation Intelligence in APAC Not every day you hear a company quietly revolutionizing an entire industry's landscape—but ISDN Holdings Limited is one of those rare players. Recognized by Frost & Sullivan for its top-tier customer value leadership, ISDN is making waves across the Asia-Pacific's industrial scene with its integrated industrial automation...

Continue Reading
MacDill Mold Case Puts Privatized Housing on Notice

Updated Category News Views 89

Four hundred fifty-four people are a hard number to shrug off. The expanded civil case over alleged toxic mold conditions at MacDill Air Force Base now covers 105 military families, up from 39 households when it was filed in September 2025. Their complaint against The Michaels Organization and affiliated entities may be the largest known military-housing lawsuit in the...

Continue Reading
Toledo Crosswalk Death Lawsuit Raises Hard Questions

Updated Category News Views 237

A painted crosswalk is supposed to mean something, and that is the grim center of the lawsuit filed over Judy Tanner’s death in Toledo. Tanner, 20, was walking home from work on September 10, 2026, when she was struck and killed while crossing the street. Her estate is now suing, alleging that the 31-year-old driver failed to yield as Tanner legally used the crosswalk....

Continue Reading

Top 5 Most Recently Viewed Articles

Olo Inc. Under Investigation for Potential Fiduciary Violations

Updated Category News Views 255

Olo Inc. Faces Investigation Over Fiduciary Duties Olo Inc. is currently under investigation by legal authorities due to possible breaches of fiduciary duty by its directors and management. This scrutiny follows Olo's announcement regarding a major acquisition deal with investment firm Thoma Bravo, valued at around $2 billion. Details of the Investigation The focus of the...

Continue Reading
Join MT Højgaard Holding's Conference Call on FY 2024 Results

Updated Category News Views 115

MT Højgaard Holding A/S Conference Call Overview MT Højgaard Holding is set to release its annual report for the fiscal year 2024 on a chosen date. Following this release, a conference call will take place where the management team will delve into the company’s performance and projections for the future. This session aims to provide insights into the results for the...

Continue Reading
ClearValue Consulting Partners with Restb.ai for Advanced Appraisals

Updated Category News Views 77

Unlocking Efficiency in Appraisal Reviews ClearValue Consulting, a leader in innovative valuation solutions, has announced an exciting new partnership with Restb.ai, a prominent name in AI-powered computer vision. This collaboration is set to redefine the appraisal review landscape, bringing in advanced technologies to streamline processes and enhance quality. The Impact...

Continue Reading
BrightSphere's Transformation: New Name and Leadership Direction

Updated Category News Views 393

BrightSphere Investment Group Inc. (NYSE: BSIG) announced its rebranding to Acadian Asset Management back in early 2025, marking a major shift in strategy. This wasn't just a name change; it was the end of their multi-boutique model and the start of a more streamlined focus on asset management. They offloaded six out of seven affiliates to zero in on core...

Continue Reading
Why Super Micro Computer’s Growth Could Still Continue

Updated Category News Views 339

Super Micro Computer (NASDAQ: SMCI) kicked off 2024 like a rocket, watching its stock explode by an eye-popping 188% in the first half. It was a remarkable performance that even left tech giants scrambling for a second look. The surge stemmed largely from surging demand for their cutting-edge workstations and servers—essential cogs in the booming artificial intelligence...

Continue Reading